Anixa Biosciences, Inc.
ANIX
$2.77
$0.000.00%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.41M | 6.63M | 6.58M | 6.87M | 7.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.03M | 11.70M | 11.99M | 13.14M | 13.61M |
| Operating Income | -11.03M | -11.70M | -11.99M | -13.14M | -13.61M |
| Income Before Tax | -10.40M | -11.03M | -11.22M | -12.25M | -12.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.40 | -11.03 | -11.22 | -12.25 | -12.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 92.00K | 101.00K | 104.00K | 120.00K | 138.00K |
| Net Income | -10.31M | -10.93M | -11.12M | -12.13M | -12.48M |
| EBIT | -11.03M | -11.70M | -11.99M | -13.14M | -13.61M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.32 | -0.34 | -0.34 | -0.38 | -0.39 |
| Normalized Basic EPS | -0.20 | -0.21 | -0.21 | -0.23 | -0.24 |
| EPS Diluted | -0.32 | -0.34 | -0.34 | -0.38 | -0.39 |
| Normalized Diluted EPS | -0.20 | -0.21 | -0.21 | -0.23 | -0.24 |
| Average Basic Shares Outstanding | 130.86M | 129.81M | 129.06M | 128.63M | 128.35M |
| Average Diluted Shares Outstanding | 130.86M | 129.81M | 129.06M | 128.63M | 128.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |